1 Introduction to Research & Analysis Reports
1.1 Peptides and Heparin Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peptides and Heparin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Peptides and Heparin Overall Market Size
2.1 Global Peptides and Heparin Market Size: 2022 VS 2029
2.2 Global Peptides and Heparin Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Peptides and Heparin Sales: 2018-2029
3 Company Landscape
3.1 Top Peptides and Heparin Players in Global Market
3.2 Top Global Peptides and Heparin Companies Ranked by Revenue
3.3 Global Peptides and Heparin Revenue by Companies
3.4 Global Peptides and Heparin Sales by Companies
3.5 Global Peptides and Heparin Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Peptides and Heparin Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Peptides and Heparin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Peptides and Heparin Players in Global Market
3.8.1 List of Global Tier 1 Peptides and Heparin Companies
3.8.2 List of Global Tier 2 and Tier 3 Peptides and Heparin Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Peptides and Heparin Market Size Markets, 2022 & 2029
4.1.2 Insulin
4.1.3 Teriparatide
4.1.4 Liraglutide
4.1.5 Leuprolide
4.1.6 Leuprolide
4.1.7 Exenatide
4.1.8 Calcitonin
4.1.9 Enaxaparin Sodium
4.1.10 Heparin Sodium
4.2 By Type – Global Peptides and Heparin Revenue & Forecasts
4.2.1 By Type – Global Peptides and Heparin Revenue, 2018-2023
4.2.2 By Type – Global Peptides and Heparin Revenue, 2024-2029
4.2.3 By Type – Global Peptides and Heparin Revenue Market Share, 2018-2029
4.3 By Type – Global Peptides and Heparin Sales & Forecasts
4.3.1 By Type – Global Peptides and Heparin Sales, 2018-2023
4.3.2 By Type – Global Peptides and Heparin Sales, 2024-2029
4.3.3 By Type – Global Peptides and Heparin Sales Market Share, 2018-2029
4.4 By Type – Global Peptides and Heparin Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Peptides and Heparin Market Size, 2022 & 2029
5.1.2 Diabetes
5.1.3 Infectious Diseases
5.1.4 Cancer
5.1.5 Osteoporosis
5.2 By Application – Global Peptides and Heparin Revenue & Forecasts
5.2.1 By Application – Global Peptides and Heparin Revenue, 2018-2023
5.2.2 By Application – Global Peptides and Heparin Revenue, 2024-2029
5.2.3 By Application – Global Peptides and Heparin Revenue Market Share, 2018-2029
5.3 By Application – Global Peptides and Heparin Sales & Forecasts
5.3.1 By Application – Global Peptides and Heparin Sales, 2018-2023
5.3.2 By Application – Global Peptides and Heparin Sales, 2024-2029
5.3.3 By Application – Global Peptides and Heparin Sales Market Share, 2018-2029
5.4 By Application – Global Peptides and Heparin Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Peptides and Heparin Market Size, 2022 & 2029
6.2 By Region – Global Peptides and Heparin Revenue & Forecasts
6.2.1 By Region – Global Peptides and Heparin Revenue, 2018-2023
6.2.2 By Region – Global Peptides and Heparin Revenue, 2024-2029
6.2.3 By Region – Global Peptides and Heparin Revenue Market Share, 2018-2029
6.3 By Region – Global Peptides and Heparin Sales & Forecasts
6.3.1 By Region – Global Peptides and Heparin Sales, 2018-2023
6.3.2 By Region – Global Peptides and Heparin Sales, 2024-2029
6.3.3 By Region – Global Peptides and Heparin Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Peptides and Heparin Revenue, 2018-2029
6.4.2 By Country – North America Peptides and Heparin Sales, 2018-2029
6.4.3 US Peptides and Heparin Market Size, 2018-2029
6.4.4 Canada Peptides and Heparin Market Size, 2018-2029
6.4.5 Mexico Peptides and Heparin Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Peptides and Heparin Revenue, 2018-2029
6.5.2 By Country – Europe Peptides and Heparin Sales, 2018-2029
6.5.3 Germany Peptides and Heparin Market Size, 2018-2029
6.5.4 France Peptides and Heparin Market Size, 2018-2029
6.5.5 U.K. Peptides and Heparin Market Size, 2018-2029
6.5.6 Italy Peptides and Heparin Market Size, 2018-2029
6.5.7 Russia Peptides and Heparin Market Size, 2018-2029
6.5.8 Nordic Countries Peptides and Heparin Market Size, 2018-2029
6.5.9 Benelux Peptides and Heparin Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Peptides and Heparin Revenue, 2018-2029
6.6.2 By Region – Asia Peptides and Heparin Sales, 2018-2029
6.6.3 China Peptides and Heparin Market Size, 2018-2029
6.6.4 Japan Peptides and Heparin Market Size, 2018-2029
6.6.5 South Korea Peptides and Heparin Market Size, 2018-2029
6.6.6 Southeast Asia Peptides and Heparin Market Size, 2018-2029
6.6.7 India Peptides and Heparin Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Peptides and Heparin Revenue, 2018-2029
6.7.2 By Country – South America Peptides and Heparin Sales, 2018-2029
6.7.3 Brazil Peptides and Heparin Market Size, 2018-2029
6.7.4 Argentina Peptides and Heparin Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Peptides and Heparin Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Peptides and Heparin Sales, 2018-2029
6.8.3 Turkey Peptides and Heparin Market Size, 2018-2029
6.8.4 Israel Peptides and Heparin Market Size, 2018-2029
6.8.5 Saudi Arabia Peptides and Heparin Market Size, 2018-2029
6.8.6 UAE Peptides and Heparin Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Cipla Ltd.
7.1.1 Cipla Ltd. Company Summary
7.1.2 Cipla Ltd. Business Overview
7.1.3 Cipla Ltd. Peptides and Heparin Major Product Offerings
7.1.4 Cipla Ltd. Peptides and Heparin Sales and Revenue in Global (2018-2023)
7.1.5 Cipla Ltd. Key News & Latest Developments
7.2 Emcure Pharmaceuticals Pvt. Ltd.
7.2.1 Emcure Pharmaceuticals Pvt. Ltd. Company Summary
7.2.2 Emcure Pharmaceuticals Pvt. Ltd. Business Overview
7.2.3 Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Major Product Offerings
7.2.4 Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Sales and Revenue in Global (2018-2023)
7.2.5 Emcure Pharmaceuticals Pvt. Ltd. Key News & Latest Developments
7.3 Gland Pharma Limited
7.3.1 Gland Pharma Limited Company Summary
7.3.2 Gland Pharma Limited Business Overview
7.3.3 Gland Pharma Limited Peptides and Heparin Major Product Offerings
7.3.4 Gland Pharma Limited Peptides and Heparin Sales and Revenue in Global (2018-2023)
7.3.5 Gland Pharma Limited Key News & Latest Developments
7.4 Troikaa Pharmaceuticals Ltd.
7.4.1 Troikaa Pharmaceuticals Ltd. Company Summary
7.4.2 Troikaa Pharmaceuticals Ltd. Business Overview
7.4.3 Troikaa Pharmaceuticals Ltd. Peptides and Heparin Major Product Offerings
7.4.4 Troikaa Pharmaceuticals Ltd. Peptides and Heparin Sales and Revenue in Global (2018-2023)
7.4.5 Troikaa Pharmaceuticals Ltd. Key News & Latest Developments
7.5 Biological E Limited
7.5.1 Biological E Limited Company Summary
7.5.2 Biological E Limited Business Overview
7.5.3 Biological E Limited Peptides and Heparin Major Product Offerings
7.5.4 Biological E Limited Peptides and Heparin Sales and Revenue in Global (2018-2023)
7.5.5 Biological E Limited Key News & Latest Developments
7.6 Bharat Biotech
7.6.1 Bharat Biotech Company Summary
7.6.2 Bharat Biotech Business Overview
7.6.3 Bharat Biotech Peptides and Heparin Major Product Offerings
7.6.4 Bharat Biotech Peptides and Heparin Sales and Revenue in Global (2018-2023)
7.6.5 Bharat Biotech Key News & Latest Developments
7.7 Samarth Life Sciences Pvt. Ltd.
7.7.1 Samarth Life Sciences Pvt. Ltd. Company Summary
7.7.2 Samarth Life Sciences Pvt. Ltd. Business Overview
7.7.3 Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Major Product Offerings
7.7.4 Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Sales and Revenue in Global (2018-2023)
7.7.5 Samarth Life Sciences Pvt. Ltd. Key News & Latest Developments
7.8 VHB Life Sciences Limited
7.8.1 VHB Life Sciences Limited Company Summary
7.8.2 VHB Life Sciences Limited Business Overview
7.8.3 VHB Life Sciences Limited Peptides and Heparin Major Product Offerings
7.8.4 VHB Life Sciences Limited Peptides and Heparin Sales and Revenue in Global (2018-2023)
7.8.5 VHB Life Sciences Limited Key News & Latest Developments
7.9 Celon Laboratories Pvt. Ltd.
7.9.1 Celon Laboratories Pvt. Ltd. Company Summary
7.9.2 Celon Laboratories Pvt. Ltd. Business Overview
7.9.3 Celon Laboratories Pvt. Ltd. Peptides and Heparin Major Product Offerings
7.9.4 Celon Laboratories Pvt. Ltd. Peptides and Heparin Sales and Revenue in Global (2018-2023)
7.9.5 Celon Laboratories Pvt. Ltd. Key News & Latest Developments
7.10 United Biotech(P) Limited
7.10.1 United Biotech(P) Limited Company Summary
7.10.2 United Biotech(P) Limited Business Overview
7.10.3 United Biotech(P) Limited Peptides and Heparin Major Product Offerings
7.10.4 United Biotech(P) Limited Peptides and Heparin Sales and Revenue in Global (2018-2023)
7.10.5 United Biotech(P) Limited Key News & Latest Developments
7.11 Biocon Limited
7.11.1 Biocon Limited Company Summary
7.11.2 Biocon Limited Peptides and Heparin Business Overview
7.11.3 Biocon Limited Peptides and Heparin Major Product Offerings
7.11.4 Biocon Limited Peptides and Heparin Sales and Revenue in Global (2018-2023)
7.11.5 Biocon Limited Key News & Latest Developments
7.12 Sun Pharmaceutical Industries Ltd.
7.12.1 Sun Pharmaceutical Industries Ltd. Company Summary
7.12.2 Sun Pharmaceutical Industries Ltd. Peptides and Heparin Business Overview
7.12.3 Sun Pharmaceutical Industries Ltd. Peptides and Heparin Major Product Offerings
7.12.4 Sun Pharmaceutical Industries Ltd. Peptides and Heparin Sales and Revenue in Global (2018-2023)
7.12.5 Sun Pharmaceutical Industries Ltd. Key News & Latest Developments
7.13 Wockhardt Ltd.
7.13.1 Wockhardt Ltd. Company Summary
7.13.2 Wockhardt Ltd. Peptides and Heparin Business Overview
7.13.3 Wockhardt Ltd. Peptides and Heparin Major Product Offerings
7.13.4 Wockhardt Ltd. Peptides and Heparin Sales and Revenue in Global (2018-2023)
7.13.5 Wockhardt Ltd. Key News & Latest Developments
8 Global Peptides and Heparin Production Capacity, Analysis
8.1 Global Peptides and Heparin Production Capacity, 2018-2029
8.2 Peptides and Heparin Production Capacity of Key Manufacturers in Global Market
8.3 Global Peptides and Heparin Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Peptides and Heparin Supply Chain Analysis
10.1 Peptides and Heparin Industry Value Chain
10.2 Peptides and Heparin Upstream Market
10.3 Peptides and Heparin Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Peptides and Heparin Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界のペプチド・ヘパリン市場予測2023-2029：インスリン、テリパラチド、リラグルチド、ロイプロリド、ロイプロリド、エクセナチド、カルシトニン、エナクサパリンナトリウム、ヘパリンナトリウム |
| 【英語タイトル】Peptides and Heparin Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5890 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：77 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界のペプチド・ヘパリン市場規模と予測を収録しています。・世界のペプチド・ヘパリン市場：売上、2018年-2023年、2024年-2029年 ・世界のペプチド・ヘパリン市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のペプチド・ヘパリン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「インスリン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ペプチド・ヘパリンのグローバル主要企業は、Cipla Ltd.、 Emcure Pharmaceuticals Pvt. Ltd.、 Gland Pharma Limited、 Troikaa Pharmaceuticals Ltd.、 Biological E Limited、 Bharat Biotech、 Samarth Life Sciences Pvt. Ltd.、 VHB Life Sciences Limited、 Celon Laboratories Pvt. Ltd.、 United Biotech(P) Limited、 Biocon Limited、 Sun Pharmaceutical Industries Ltd.、 Wockhardt Ltd.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、ペプチド・ヘパリンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のペプチド・ヘパリン市場：タイプ別、2018年-2023年、2024年-2029年 世界のペプチド・ヘパリン市場：タイプ別市場シェア、2022年 ・インスリン、テリパラチド、リラグルチド、ロイプロリド、ロイプロリド、エクセナチド、カルシトニン、エナクサパリンナトリウム、ヘパリンナトリウム 世界のペプチド・ヘパリン市場：用途別、2018年-2023年、2024年-2029年 世界のペプチド・ヘパリン市場：用途別市場シェア、2022年 ・糖尿病、感染症、がん、骨粗鬆症 世界のペプチド・ヘパリン市場：地域・国別、2018年-2023年、2024年-2029年 世界のペプチド・ヘパリン市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるペプチド・ヘパリンのグローバル売上、2018年-2023年 ・主要企業におけるペプチド・ヘパリンのグローバル売上シェア、2022年 ・主要企業におけるペプチド・ヘパリンのグローバル販売量、2018年-2023年 ・主要企業におけるペプチド・ヘパリンのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Cipla Ltd.、 Emcure Pharmaceuticals Pvt. Ltd.、 Gland Pharma Limited、 Troikaa Pharmaceuticals Ltd.、 Biological E Limited、 Bharat Biotech、 Samarth Life Sciences Pvt. Ltd.、 VHB Life Sciences Limited、 Celon Laboratories Pvt. Ltd.、 United Biotech(P) Limited、 Biocon Limited、 Sun Pharmaceutical Industries Ltd.、 Wockhardt Ltd. ************************************************************* ・調査・分析レポートの概要 ペプチド・ヘパリン市場の定義 市場セグメント 世界のペプチド・ヘパリン市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のペプチド・ヘパリン市場規模 世界のペプチド・ヘパリン市場規模：2022年 VS 2029年 世界のペプチド・ヘパリン市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのペプチド・ヘパリンの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のペプチド・ヘパリン製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：インスリン、テリパラチド、リラグルチド、ロイプロリド、ロイプロリド、エクセナチド、カルシトニン、エナクサパリンナトリウム、ヘパリンナトリウム ペプチド・ヘパリンのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：糖尿病、感染症、がん、骨粗鬆症 ペプチド・ヘパリンの用途別グローバル売上・予測 ・地域別市場分析 地域別ペプチド・ヘパリン市場規模 2022年と2029年 地域別ペプチド・ヘパリン売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Cipla Ltd.、 Emcure Pharmaceuticals Pvt. Ltd.、 Gland Pharma Limited、 Troikaa Pharmaceuticals Ltd.、 Biological E Limited、 Bharat Biotech、 Samarth Life Sciences Pvt. Ltd.、 VHB Life Sciences Limited、 Celon Laboratories Pvt. Ltd.、 United Biotech(P) Limited、 Biocon Limited、 Sun Pharmaceutical Industries Ltd.、 Wockhardt Ltd. ... |
This report aims to provide a comprehensive presentation of the global market for Peptides and Heparin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptides and Heparin. This report contains market size and forecasts of Peptides and Heparin in global, including the following market information:
Global Peptides and Heparin Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Peptides and Heparin Market Sales, 2018-2023, 2024-2029, (K Pcs)
Global top five Peptides and Heparin companies in 2022 (%)
The global Peptides and Heparin market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Insulin Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Peptides and Heparin include Cipla Ltd., Emcure Pharmaceuticals Pvt. Ltd., Gland Pharma Limited, Troikaa Pharmaceuticals Ltd., Biological E Limited, Bharat Biotech, Samarth Life Sciences Pvt. Ltd., VHB Life Sciences Limited and Celon Laboratories Pvt. Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Peptides and Heparin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peptides and Heparin Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Peptides and Heparin Market Segment Percentages, by Type, 2022 (%)
Insulin
Teriparatide
Liraglutide
Leuprolide
Leuprolide
Exenatide
Calcitonin
Enaxaparin Sodium
Heparin Sodium
Global Peptides and Heparin Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Peptides and Heparin Market Segment Percentages, by Application, 2022 (%)
Diabetes
Infectious Diseases
Cancer
Osteoporosis
Global Peptides and Heparin Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Peptides and Heparin Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peptides and Heparin revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Peptides and Heparin revenues share in global market, 2022 (%)
Key companies Peptides and Heparin sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Peptides and Heparin sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cipla Ltd.
Emcure Pharmaceuticals Pvt. Ltd.
Gland Pharma Limited
Troikaa Pharmaceuticals Ltd.
Biological E Limited
Bharat Biotech
Samarth Life Sciences Pvt. Ltd.
VHB Life Sciences Limited
Celon Laboratories Pvt. Ltd.
United Biotech(P) Limited
Biocon Limited
Sun Pharmaceutical Industries Ltd.
Wockhardt Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Peptides and Heparin, market overview.
Chapter 2: Global Peptides and Heparin market size in revenue and volume.
Chapter 3: Detailed analysis of Peptides and Heparin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Peptides and Heparin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Peptides and Heparin capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界のペプチド・ヘパリン市場予測2023-2029：インスリン、テリパラチド、リラグルチド、ロイプロリド、ロイプロリド、エクセナチド、カルシトニン、エナクサパリンナトリウム、ヘパリンナトリウム] (コード：MMG23JU5890)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界のペプチド・ヘパリン市場予測2023-2029：インスリン、テリパラチド、リラグルチド、ロイプロリド、ロイプロリド、エクセナチド、カルシトニン、エナクサパリンナトリウム、ヘパリンナトリウム]についてメールでお問い合わせ |
